Meyka Pro is live. Get 50% off your first 3 months.Get Started →
Meyka Pro banner
Revolution Medicines, Inc.

Revolution Medicines, Inc. (RVMD) Stock Overview

Explore Revolution Medicines, Inc.’s financial performance, market position, analyst ratings, and future outlook.

RVMD●NASDAQ
HealthcareBiotechnology
$196.35
$13.90(7.62%)
U.S. Market is Open · 15:27

Revolution Medicines, Inc. (RVMD)

Meyka AI Score

Z

Key Financials

Market Cap41.1B
P/E Ratio-27.10
EPS (TTM)$-7.07
ROE-0.83%
Fundamental Analysis

AI Price Forecasts

1 Month$182.90
3 Months$208.91
1 Year Target$143.35

RVMD Stock Analysis & Investment Overview (NASDAQ)

Our AI-powered analysis of Revolution Medicines, Inc. (NASDAQ: RVMD) gives investors deep insight into how the stock performs on the NASDAQ exchange, its growth potential, and its market positioning. With a Meyka AI Score of B, Revolution Medicines, Inc.'s NASDAQ-listed shares demonstrate moderate investment characteristics based on our machine learning models.

The current technical analysis of RVMD on the NASDAQ shows an RSI of 59.56, suggesting the stock is in a a neutral condition. Our forecasting models predict a 12-month price target of $143.35 for the NASDAQ listing.

Key metrics behind Revolution Medicines, Inc.'s NASDAQ-traded stock include a P/E ratio of -27.10 and a market capitalization of 41.1B. Combined with our AI analysis, these give both institutional and retail investors a clear view of RVMD on the NASDAQ.

Price Performance (NASDAQ: RVMD)

1-Day Change
6.03%
5-Day Change
5.30%
1-Month Change
1.83%
3-Month Change
30.80%
6-Month Change
100.46%
Year-to-Date (YTD) Change
142.89%
1-Year Change
420.33%
3-Year Change
519.87%
5-Year Change
601.70%
All-Time (Max) Change
569.41%

Contact Information

https://www.revmed.com
650 481 6801
700 Saginaw Drive, Redwood City, CA, 94063

Company Facts

8,830 Employees
IPO DateFeb 13, 2020
CountryUS
Actively Trading

Frequently Asked Questions